Do micropapillary patients benefit from chemotherapy?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Do micropapillary patients benefit from chemotherapy?

Published:2017-04-09 Issue:5 Volume:119 Page:656-658
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

von Landenberg Nicolas¹²,Speed Jacqueline M.¹,Trinh Quoc-Dien¹

Affiliation:

1. Division of Urological Surgery; Brigham and Women's Hospital; Harvard Medical School; Boston MA USA

2. Department of Urology; Marien Hospital Herne; Ruhr-University Bochum; Herne Germany

Funder

Vattikuti Urology Institute

Prostate Cancer Foundation

Conquer Cancer Foundation of the American Society of Clinical Oncology

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13780/fullpdf

Reference7 articles.

1. Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer;Fernandez;BJU Int,2017

2. Should histologic variants alter definitive treatment of bladder cancer?;Willis;Curr Opin Urol,2013

3. Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder;Ghoneim;Urology,2011

4. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003

5. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients;Kamat;Cancer,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder;Urologic Oncology: Seminars and Original Investigations;2023-02

2. Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies;Investigative and Clinical Urology;2023

3. Bladder Preservation for Muscle-Invasive Bladder Cancer With Variant Histology;Seminars in Radiation Oncology;2023-01

4. Cancer Antigen 15-3 Serum Level as a Biomarker for Advanced Micropapillary Urothelial Carcinoma of the Bladder: A Case Report;Case Reports in Oncology;2021-06-29

5. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence;European Urology Focus;2020-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3